mMe: Motivational Monitoring to Enhance Smoking Cessation Among Cancer Patients

Cancer Clinical Trial

— mMe  

Official title:

Motivational Monitoring to Enhance Smoking Cessation Among Cancer Patients Pilot Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05370859
• Other study ID #: 18184
• Status: Completed
• Start date: July 18, 2022
• Est. completion date: February 13, 2024

Study information

• Verified date: April 2024
• Source: University of Virginia
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The objectives of this study are to pilot test a protocol of weekly assessments of motivation to quit and other relevant constructs combined with information about how to enroll in cessation programs, which will allow initial quantification of motivation to quit during cancer treatment and develop hypotheses about the impact of motivation on the decision to enroll in services.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 25
• Est. completion date: February 13, 2024
• Est. primary completion date: February 13, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• An adult (18+)

• Current smoker defined by: Has smoked 100 cigarettes in their lifetime (may be multi-tobacco users as long as they also use combustible cigarettes).

• Any type of cancer (except non-melanoma skin cancer)

• Anticipates receiving any of the following cancer treatments in the 3 months following enrollment: chemotherapy, surgery, immunotherapy, bone marrow or stem cell transplant, hormone therapy, or radiation

• Access to the Internet

Exclusion Criteria:

• Not smoked 100 cigarettes in their lifetime

• < 18 years in age

• Diagnosed with non-melanoma skin cancer

• Not diagnosed with cancer

• Does not anticipate receiving cancer treatments in the 3 months following enrollment

• Has been previously enrolled in an existing Cancer Center Tobacco Treatment Program (TTP)

• Not comfortable reading and responding to questions in English

• No consistent access to the Internet

Related Conditions & MeSH terms

• Cancer
• Motivation
• Smoking Behaviors

Intervention

Other:
• There is no intervention for this study
There is no intervention or exposure for this study

Locations

Country	Name	City	State
United States	University of Virginia Cancer Center and affiliated sites	Charlottesville	Virginia

Sponsors (1)

Lead Sponsor	Collaborator
University of Virginia

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of participants who enroll in cessation services	Assessed using administrative records	12 weeks after study start
Secondary	Level of and change in motivation and self-efficacy to quit smoking	Assessed using self-report on the weekly and 12-week survey	Through study completion, an average of 12 weeks
Secondary	Level of and change in anxiety and depression	Assessed using self-report (PHQ-4) on the weekly and 12-week survey	Through study completion, an average of 12 weeks
Secondary	Number of smoking quit attempts	Assessed using self-report on the weekly and 12-week survey	12 weeks after study start